ProfileGDS4718 / 220905_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 69% 60% 66% 75% 65% 61% 62% 64% 60% 65% 77% 69% 61% 65% 59% 61% 66% 65% 89% 66% 63% 61% 63% 72% 61% 65% 74% 73% 64% 67% 61% 73% 67% 62% 61% 68% 65% 67% 54% 63% 70% 64% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7245268
GSM549102patient 115, normal, homogenized [OPG study]6.7646769
GSM549104patient 119, normal, homogenized [OPG study]6.1768760
GSM549108patient 138, normal, homogenized [OPG study]6.556266
GSM549119patient 077, normal, homogenized [OPG study]7.276575
GSM549133patient 032, cancer, homogenized [OPG study]6.4756865
GSM549139patient 042, cancer, homogenized [OPG study]6.1902761
GSM549099patient 107, normal, homogenized [OPG study]6.275862
GSM549109patient 139, normal, homogenized [OPG study]6.4043764
GSM549110patient 046, normal, homogenized [OPG study]6.1038160
GSM549114patient 063, normal, homogenized [OPG study]6.4678265
GSM549122patient 082, normal, homogenized [OPG study]7.5540377
GSM549134patient 033, cancer, homogenized [OPG study]6.8133469
GSM549136patient 036, cancer, homogenized [OPG study]6.2046761
GSM549140patient 044, cancer, homogenized [OPG study]6.478165
GSM549111patient 047, normal, homogenized [OPG study]6.0906459
GSM549113patient 057, normal, homogenized [OPG study]6.1439161
GSM549132patient 031, cancer, homogenized [OPG study]6.532766
GSM549137patient 038, cancer, homogenized [OPG study]6.4961465
GSM549142patient 047, cancer, homogenized [OPG study]8.6504789
GSM549100patient 110, normal, homogenized [OPG study]6.4962166
GSM549107patient 135, normal, homogenized [OPG study]6.2975963
GSM549115patient 068, normal, homogenized [OPG study]6.1940161
GSM549116patient 072, normal, homogenized [OPG study]6.3465463
GSM549120patient 078, normal, homogenized [OPG study]7.0637472
GSM549131patient 030, cancer, homogenized [OPG study]6.1597561
GSM549118patient 074, normal, homogenized [OPG study]6.474765
GSM549129patient 027, cancer, homogenized [OPG study]7.3036274
GSM549123patient 088, normal, homogenized [OPG study]7.1607573
GSM549124patient 006, cancer, homogenized [OPG study]6.3936664
GSM549126patient 015, cancer, homogenized [OPG study]6.5936767
GSM549128patient 025, cancer, homogenized [OPG study]6.2056361
GSM549103patient 117, normal, homogenized [OPG study]7.0748873
GSM549117patient 073, normal, homogenized [OPG study]6.5516167
GSM549138patient 041, cancer, homogenized [OPG study]6.2888862
GSM549141patient 045, cancer, homogenized [OPG study]6.1943461
GSM549130patient 028, cancer, homogenized [OPG study]6.6582768
GSM549101patient 111, normal, homogenized [OPG study]6.5327365
GSM549105patient 128, normal, homogenized [OPG study]6.6018367
GSM549106patient 134, normal, homogenized [OPG study]5.7091854
GSM549112patient 048, normal, homogenized [OPG study]6.3018963
GSM549125patient 011, cancer, homogenized [OPG study]6.8580570
GSM549127patient 024, cancer, homogenized [OPG study]6.4996264
GSM549135patient 035, cancer, homogenized [OPG study]6.2526762